Cumberland Pharmaceuticals Inc
CPIX Real Time Price USDRecent trades of CPIX by members of U.S. Congress
No Congress Trading data for this ticker
Congress Trading Dashboard
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by CPIX's directors and management
Government lobbying spending instances
-
$20,000 Jan 21, 2021 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Injectable ibuprofen formulation Nov. 07, 2023
-
Patent Title: Thromboxane receptor antagonists in aerd/asthma Feb. 07, 2023
-
Patent Title: Compositions and methods of treating cardiac fibrosis with ifetroban Feb. 23, 2021
-
Patent Title: Doses and methods for administering telavancin Aug. 25, 2020
-
Patent Title: Compositions and methods of treating cardiac fibrosis with ifetroban Mar. 10, 2020
-
Patent Title: Compositions and methods of treating muscular dystrophy with thromboxane-a Oct. 29, 2019
-
Patent Title: Compositions and methods of treating cardiac fibrosis with ifetroban Jun. 11, 2019
-
Patent Title: Compositions and methods of treating muscular dystrophy with thromboxane-a Sep. 04, 2018
-
Patent Title: Compositions and methods of treating cardiac fibrosis with ifetroban Jul. 10, 2018
-
Patent Title: Treating critically ill patients with intravenous ibuprofen Apr. 03, 2018
-
Patent Title: Stabilized statin formulations Nov. 21, 2017
-
Patent Title: Compositions and methods of treating cardiac fibrosis with ifetroban Jul. 04, 2017
-
Patent Title: Treating critically ill patients with intravenous ibuprofen May. 16, 2017
-
Patent Title: Lactulose for bowel evacuation Jun. 28, 2016
-
Patent Title: Acetylcysteine compositions and methods of use thereof May. 03, 2016
-
Patent Title: Treating critically ill patients with intravenous ibuprofen Mar. 29, 2016
-
Patent Title: Treating critically ill patients with intravenous ibuprofen Sep. 22, 2015
-
Patent Title: Treating patients with intravenous ibuprofen Aug. 25, 2015
-
Patent Title: Injectable ibuprofen formulation Jul. 07, 2015
-
Patent Title: Injectable ibuprofen formulation Jul. 07, 2015
-
Patent Title: Administration of intravenous ibuprofen Apr. 21, 2015
-
Patent Title: Acetylcysteine composition and uses thereof Feb. 10, 2015
-
Patent Title: Stabilized statin formulations Jan. 13, 2015
-
Patent Title: Treating critically ill patients with intravenous ibuprofen Oct. 28, 2014
-
Patent Title: Lactulose for bowel evacuation Jul. 15, 2014
-
Patent Title: Treating patients with intravenous ibuprofen May. 27, 2014
-
Patent Title: Acetycysteine compositions and methods of use thereof May. 13, 2014
-
Patent Title: Acetylcysteine composition and uses thereof Feb. 18, 2014
-
Patent Title: Acetylcysteine composition and uses thereof Mar. 19, 2013
-
Patent Title: Stabilized statin formulations Feb. 12, 2013
-
Patent Title: Acetylcysteine composition and uses therefor Apr. 03, 2012
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of CPIX in WallStreetBets Daily Discussion
Recent insights relating to CPIX
Recent picks made for CPIX stock on CNBC
ETFs with the largest estimated holdings in CPIX
Shareholder
|
Shares Held
|
---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CPIX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.